Hi H. I like your post, thought out and logic to it. I agree...

Hi H. I like your post, thought out and logic to it. I agree that the uptake by drs across the board for multiple indications will be a very slow process due to the reasons you list but i think the $100mill contract equivalent sits in our ability to diagnose CB for the veterans...if we can get into that narrow but deep stream, that will be a game changer. Andreas has previously said that this is 4dx most important focus atm, getting into this market. The clinical trials and the relationships built with Vanderbilt etc...i think there is a chance this could come together in the near term. This, with use of scanners as the halo effect over the company and we will have a near term rosy outlook. If we miss out on this one, then yes, i agree that the path forward will be alot slower!